NDC product
Macrilen
NDC 0169-1401 · Novo Nordisk
Key facts
| Product NDC | 0169-1401 |
|---|---|
| Proprietary name | Macrilen |
| Nonproprietary name | Macimorelin acetate |
| Substances | MACIMORELIN |
| Dosage form | GRANULE, FOR SOLUTION |
| Route | ORAL |
| Labeler | Novo Nordisk |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA205598 |
| Pharmacologic classes | Growth Hormone Secretagogue Receptor Agonist [EPC], Growth Hormone Secretagogue Receptor Agonists [MoA] |
| Marketing start | Jan 31, 2022 |
| Marketing end | Feb 28, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory